Product Investigation

Sildalis

A combination tablet claiming both sildenafil and tadalafil — a pairing with no approved equivalent in the US.

Image not yet available

Claimed Active Ingredient: Sildenafil + Tadalafil Claimed
Claimed Strength: Commonly advertised as 100 mg sildenafil + 20 mg tadalafil (claimed)
Product Category: Imported Combination Product
Country / Market: Not verified
FDA Status: Not FDA approved. No sildenafil–tadalafil combination tablet is FDA approved.
Evidence Grade: ?Not Enough Reliable Information
Verification Level: Unverified
Regulatory Status: Not FDA Approved
Real-World Signal: Sold online as an imported combination; SynMale has not confirmed lab analysis of any lot.

Seller and label claims are shown as claims. SynMale does not treat them as verified facts.

Known Regulatory Warnings

SynMale has not yet confirmed a specific regulatory warning naming this product. Pending source review.

Actual content of either drug in any package.
Safety of combining two PDE5 inhibitors at these doses — not established in approved labeling.

Claim
“Fast onset plus long duration”

Evidence
A plausible-sounding rationale, but combining two PDE5 inhibitors has not been established as safe or more effective in approved labeling.

Combining any PDE5 inhibitor with nitrates or riociguat can cause a severe, potentially life-threatening drop in blood pressure.
Buying without a prescription removes clinician screening for heart conditions and interacting medications.
Two drugs with the same mechanism can add up, increasing risk of side effects and low blood pressure.

SynMale Verdict

HIGH CAUTION

Combines two drugs of the same class without an approved basis, from a source whose contents cannot be verified.